A case of acute generalized exanthematous pustulosis caused by exposure to Atovaquone/proguanil

J Travel Med. 2020 Sep 26;27(6):taaa034. doi: 10.1093/jtm/taaa034.

Authors

Marta Arsuaga¹, Rosa de Miguel¹, Elena Trigo¹, Pablo Barreiro¹, Fernando de la Calle¹, Eloy José Tarin², D Loli-Ausejo³, Marta Diaz¹

Affiliations

¹ National Referral Unit for Tropical and Travel Medicine, University Hospital La Paz - Carlos III, Paseo de la Castellana 261, Madrid. CP 28046, Madrid, Spain.
² Department of Dermatology, University Hospital La Paz- Carlos III, Paseo de la Castellana 261, Madrid. CP 28046, Madrid, Spain.
³ Department of Allergology, University Hospital La Paz - Carlos III, Paseo de la Castellana 261, Madrid. CP 28046, Madrid, Spain.

PMID: 32163144
DOI: 10.1093/jtm/taaa034

No abstract available

Keywords: Antimalarials; adverse event; drug surveillance; returning travelers; skin lesions; toxicity; tropics.

Publication types

Case Reports

MeSH terms

Acute Generalized Exanthematous Pustulosis* / diagnosis
Acute Generalized Exanthematous Pustulosis* / drug therapy
Acute Generalized Exanthematous Pustulosis* / etiology
Antimalarials* / therapeutic use
Atovaquone / adverse effects
Drug Combinations
Humans
Malaria* / drug therapy
Malaria, Falciparum* / drug therapy
Proguanil / adverse effects

Substances

Antimalarials
Drug Combinations
Proguanil
Atovaquone